• Advanced gene delivery system secures Japan patent

Company News

Advanced gene delivery system secures Japan patent

Jan 17 2024

ProBioGen has announced that the Japan Patent Office (JPO) has granted the first patent for the company’s DirectedLuck® technology. This advanced gene delivery system is anchored in a highly potent transposase fusion variant, facilitating epigenetic targeting alongside a meticulously designed transposon.

Dr Volker Sandig, Chief Scientific Officer of ProBioGen, emphasised the significance of this patent grant for the ground-breaking cell-engineering technology. The plug-and-play system offers advantages throughout the biopharmaceutical value chain, enabling accelerated timelines for clinical applications. Dr Sandig stated: ‘‘Thanks to our DirectedLuck® technology, clients attain higher titres and maximum stability within condensed timelines.’’

ProBioGen has successfully implemented DirectedLuck® to generate numerous producer cell lines for clients, garnering endorsement from ProBioGen’s licensees. Beyond its application in generating producer cell lines, DirectedLuck® proves versatile for creating stable packaging cell lines for viral vectors and finds utility in gene and cell therapy.

More information online


Digital Edition

ILM 49.5 July

July 2024

Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...

View all digital editions

Events

HPLC 2024

Jul 20 2024 Denver, CO, USA

ICMGP 2024

Jul 21 2024 Cape Town, South Africa

ADLM 2024

Jul 28 2024 San Diego, CA USA

InaLab 2024

Jul 30 2024 Jakarta, Indonesia

Miconex

Jul 31 2024 Chengdu, China

View all events